Back to Search
Start Over
Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature
- Source :
- Clinical Case Reports, Vol 8, Iss 12, Pp 3042-3048 (2020)
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- Abstract Scleromyxedema is a rare and progressive disease that currently has no standard treatment. Triplet therapy with lenalidomide, bortezomib, and dexamethasone can be an effective therapy for scleromyxedema, especially in patients with refractory or relapsed disease.
Details
- Language :
- English
- ISSN :
- 20500904
- Volume :
- 8
- Issue :
- 12
- Database :
- Directory of Open Access Journals
- Journal :
- Clinical Case Reports
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.6734df26ec944433a2128cad41e2e9fc
- Document Type :
- article
- Full Text :
- https://doi.org/10.1002/ccr3.3302